三元基因
(837344)
| 流通市值：19.65亿 | | | 总市值：21.07亿 |
| 流通股本：1.14亿 | | | 总股本：1.22亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 168,404,084.66 | 117,163,967.93 | 47,952,373.12 | 244,732,951.33 |
| 营业收入 | 168,404,084.66 | 117,163,967.93 | 47,952,373.12 | 244,732,951.33 |
| 二、营业总成本 | 159,306,436.48 | 107,606,387.37 | 46,920,517.51 | 209,869,414.6 |
| 营业成本 | 30,944,379.59 | 21,947,612.44 | 9,185,324.05 | 49,711,672.95 |
| 税金及附加 | 4,365,626.47 | 2,803,954.57 | 1,180,038.31 | 2,022,117.4 |
| 销售费用 | 78,221,814.38 | 53,760,558.49 | 23,449,038.47 | 113,169,553.36 |
| 管理费用 | 25,778,887.04 | 19,598,248.55 | 8,891,814.59 | 31,269,553.92 |
| 研发费用 | 13,059,388.26 | 6,362,596.17 | 2,924,856.44 | 13,079,346.1 |
| 财务费用 | 6,936,340.74 | 3,133,417.15 | 1,289,445.65 | 617,170.87 |
| 其中:利息费用 | 7,976,394.29 | 3,872,174.49 | 1,747,969.35 | 2,524,664.99 |
| 其中:利息收入 | 1,060,951.49 | 751,201.63 | 464,427.2 | 1,934,174.57 |
| 资产处置收益 | 29,536.8 | 29,536.8 | - | 0 |
| 资产减值损失(新) | -269,410.49 | -269,341.62 | -5,040.72 | -1,111.23 |
| 信用减值损失(新) | 1,702,230.07 | 1,150,656.61 | 734,025.45 | -1,921,791.08 |
| 其他收益 | 1,991,947.58 | 882,208.2 | 479,528.82 | 3,094,070.98 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 12,551,952.14 | 11,350,640.55 | 2,240,369.16 | 36,034,705.4 |
| 加:营业外收入 | 16,283.03 | 13,922.91 | 7.47 | 2,893.17 |
| 减:营业外支出 | 61,104.32 | 10,066.63 | 4,895.75 | 423,166.22 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 12,507,130.85 | 11,354,496.83 | 2,235,480.88 | 35,614,432.35 |
| 减:所得税费用 | 652,668.1 | 1,688,471.95 | 307,082.7 | 3,932,714.76 |
| 六、净利润 | 11,854,462.75 | 9,666,024.88 | 1,928,398.18 | 31,681,717.59 |
| 持续经营净利润 | 11,854,462.75 | 9,666,024.88 | 1,928,398.18 | 31,681,717.59 |
| 归属于母公司股东的净利润 | 11,854,462.75 | 9,666,024.88 | 1,928,398.18 | 31,681,717.59 |
| (一)基本每股收益 | 0.1 | 0.08 | 0.02 | 0.26 |
| (二)稀释每股收益 | 0.1 | 0.08 | 0.02 | 0.26 |
| 九、综合收益总额 | 11,854,462.75 | 9,666,024.88 | 1,928,398.18 | 31,681,717.59 |
| 归属于母公司股东的综合收益总额 | 11,854,462.75 | 9,666,024.88 | 1,928,398.18 | 31,681,717.59 |
| 公告日期 | 2024-10-30 | 2024-08-26 | 2024-04-26 | 2024-04-15 |
| 审计意见(境内) | | | | 标准无保留意见 |